In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

• Forschungsstelle: INNOSUISSE
• Projektnummer: 128.411 INNO-LS
• Projekttitel Englisch: In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

Schlüsselwörter (Englisch)

Life sciences, Biotechnology and processing

Abstract (Englisch)

Abbmira and ZHAW are collaborating to advance Compound42, a drug designed to support the native immune system?s fight against cancer. ZHAW?s experiments using state-of-the art in vitro laboratory-models will generate critical data for guiding further drug-development and future clinical trials.